Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial Dr.

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Volume 387, Issue 10037, Pages (June 2016)

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration Alasdair Reid, MD, Fabio Scano,

Enhanced performance feedback and patient participation to improve hand hygiene compliance of health-care workers in the setting of established multimodal.

Volume 379, Issue 9824, Pages (April 2012)

Volume 357, Issue 9273, Pages (June 2001)

Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies Lauren J Ralph, MPH, Sandra I McCoy, PhD, Karen.

Volume 367, Issue 9517, Pages (April 2006)

Volume 357, Issue 9257, Pages (March 2001)

Volume 370, Issue 9601, Pages (November 2007)

Volume 359, Issue 9322, Pages (June 2002)

Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa Prof Tonya Renee Thurman,

Volume 378, Issue 9785, Pages (July 2011)

Volume 376, Issue 9734, Pages (July 2010)

Year-round influenza immunisation during pregnancy in Nepal: a phase 4, randomised, placebo-controlled trial Prof Mark C Steinhoff, MD, Prof Joanne Katz,

Thank God for Richard Dawkins?

Volume 10, Issue 12, Pages (December 2011)

Volume 372, Issue 9633, Pages (July 2008)

Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis Katharina Kranzer,

Brian J Coburn, David J Gerberry, Sally Blower

The effect of community-based support for caregivers on the risk of virological failure in children and adolescents with HIV in Harare, Zimbabwe (ZENITH):

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Volume 371, Issue 9611, Pages (February 2008)

Volume 376, Issue 9734, Pages (July 2010)

Volume 9, Issue 5, Pages (May 2008)

Volume 4, Issue 10, Pages e457-e464 (October 2017)

Volume 372, Issue 9633, Pages (July 2008)

Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled.

Volume 377, Issue 9759, Pages (January 2011)

Volume 389, Issue 10071, Pages (February 2017)

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials David Moher, MSc, Kenneth F Schulz,

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes:

Volume 374, Issue 9707, Pages (December 2009)

Strengthening capacity for health research in Africa

Volume 9, Issue 10, Pages (October 2008)

Volume 10, Issue 4, Pages (April 2011)

Disease and stigma The Lancet Volume 354, (December 1999)

Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised,

Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled.

Resuscitation at birth and cognition at 8 years of age: a cohort study

James E Scriven, David G Lalloo, Graeme Meintjes

Volume 4, Issue 6, Pages (June 2017)

Volume 379, Issue 9821, Pages (March 2012)

Volume 379, Issue 9812, Pages (January 2012)

Volume 378, Issue 9785, Pages (July 2011)

Effect of antenatal multiple micronutrient supplementation on anthropometry and blood pressure in mid-childhood in Nepal: follow-up of a double-blind.

Cold water immersion: sudden death and prolonged survival

Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double- blind, parallel-group, placebo-controlled trial Dr Andrew R Goudie,

Amanda Rojek, MBBS, Prof Peter Horby, FRCP, Dr Jake Dunning, MRCP

Volume 376, Issue 9749, Pages (October 2010)

Confessions of a journal junkie

Pre-entry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysis Dr Robert W Aldridge, MSc,

Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England.

Volume 372, Issue 9647, Pages (October 2008)

Effect of a bereavement support group on female adolescents' psychological health: a randomised controlled trial in South Africa Prof Tonya Renee Thurman,

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial

Volume 5, Issue 2, Pages (February 2018)

Volume 15, Issue 13, Pages (December 2014)

Neuromuscular electrical stimulation to improve exercise capacity in patients with severe COPD: a randomised double-blind, placebo-controlled trial Dr.

Thank God for Richard Dawkins?

Low-technology approaches

Volume 386, Issue 10005, Pages (October 2015)

Volume 375, Issue 9714, Pages (February 2010)

Effect of a behaviour change intervention on the quality of peri-urban sanitation in Lusaka, Zambia: a randomised controlled trial James B Tidwell, PhD,

Integrating an early childhood development programme into Bangladeshi primary health-care services: an open-label, cluster-randomised controlled trial

Volume 385, Issue 9985, Pages (June 2015)

Volume 383, Issue 9930, Pages (May 2014)

Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,

Volume 371, Issue 9611, Pages (February 2008)

Volume 18, Issue 6, Pages (June 2019)

Presentation transcript:

Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial Dr Rosalind Parkes-Ratanshi, PhD, Katie Wakeham, MRCP, Prof Jonathan Levin, PhD, Deodata Namusoke, MA, James Whitworth, PhD, Alex Coutinho, MPH, Nathan Kenya Mugisha, MPH, Prof Heiner Grosskurth, PhD, Anatoli Kamali, MSc, Prof David G Lalloo, FRCP The Lancet Infectious Diseases Volume 11, Issue 12, Pages 933-941 (December 2011) DOI: 10.1016/S1473-3099(11)70245-6 Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile The Lancet Infectious Diseases 2011 11, 933-941DOI: (10.1016/S1473-3099(11)70245-6) Copyright © 2011 Elsevier Ltd Terms and Conditions

Figure 2 Incidence of cryptococcal disease by treatment group The Lancet Infectious Diseases 2011 11, 933-941DOI: (10.1016/S1473-3099(11)70245-6) Copyright © 2011 Elsevier Ltd Terms and Conditions